FDA green-lights breast thermography system

Lisa Fratt | | Health Imaging | Diagnostic Imaging
The FDA has cleared UE LifeSciences NoTouch BreastScan as an adjunctive diagnostic screening tool for the detection of breast cancer.

NoTouch BreastScan is a computerized functional infrared imaging system with a dual-infrared detector design. It does not require manual interpretation of thermal data; instead, it analyzes temperature pixels from various infrared frames to create a report.

The Philadelphia-based developer of breast cancer detection systems plans to offer NoTouch BreastScan services to gynecology, medical oncology and radiology clinics in the U.S. starting in the New York, New Jersey and Pennsylvania regions.

Lisa Fratt

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.